Pharmacology, Toxicology and Pharmaceutical Science
Drug
100%
Oxaliplatin
79%
Peripheral Neuropathy
59%
Oxaliplatin-Induced Peripheral Neuropathy
52%
Paclitaxel
37%
Malignant Neoplasm
34%
Pancreas Cancer
32%
Mouse
29%
Omeprazole
28%
Chemotherapy
24%
Gemcitabine
23%
Leukemia
23%
Myelodysplastic Syndrome
23%
ABCG2
23%
Neoplasm
23%
Mechanical Allodynia
22%
Adverse Event
22%
Fumaric Acid Dimethyl Ester
21%
Diseases
20%
Clinical Research
19%
Therapeutic Drug Monitoring
19%
Paroxetine
19%
Rodent
18%
Nerve Fiber Degeneration
18%
Neuropathy
17%
Incidence
17%
Stomach Cancer
15%
Bortezomib
15%
Clinical Trial
15%
Community Pharmacy
14%
Bisphosphonic Acid Derivative
14%
Kampo Medicine (Drug)
13%
Cold Hyperalgesia
13%
Clinical Study
13%
Chronic Disease
13%
Anticarcinogen
13%
Neuroprotective Agent
12%
Messenger RNA
12%
Rat Model
12%
Rat
12%
Proton Pump Inhibitor
12%
Nausea
11%
Capecitabine
11%
Hand Foot Syndrome
11%
Donepezil
11%
Endometrium Cancer
11%
Cystine
11%
Benzodiazepine Receptor Stimulating Agent
11%
Fresh Water
11%
Nutmeg
11%
Medicine and Dentistry
Patient
25%
Oxaliplatin
21%
Chemotherapeutic Agent
15%
Drug
15%
Neuropathy
13%
Symptom
13%
Male
11%
Hand Foot Syndrome
11%
Capecitabine
11%
Bortezomib
11%
Female
11%
Mechanical Allodynia
11%
Oxaliplatin-Induced Peripheral Neuropathy
11%
Pharmacist
11%
Fresh Water
11%
Comprehension
11%
Monitoring
10%
Paclitaxel
9%
Peripheral Neuropathy
9%
Physician
9%
Trough Level
8%
Child
8%
Proton-Pump Inhibitor
8%
Laryngectomy
8%
Nervous System
7%
Cold Hyperalgesia
7%
Therapeutic Drug Monitoring
7%
Edema
7%
Outpatient
7%
Omeprazole
6%
Kampo
6%
Measurement
5%
Examination
5%
Duloxetine
5%
Bioelectrical Impedance Analysis
5%
Evaluation Study
5%
Serositis
5%
Teicoplanin
5%
Medicine
5%
Health
5%
Biochemistry, Genetics and Molecular Biology
ABCC3
23%
Omeprazole
21%
Protein
20%
Promoter Region
18%
Nested Gene
17%
Data Base
16%
Placental Mammal
15%
Messenger RNA
15%
Allele
14%
Sample
14%
Rodent
13%
CpG Island
8%
Reporter Gene
7%
Methylation
6%
Haplotype
6%
Mutation
6%
Glucose Metabolism
5%
Ccaat-Enhancer-Binding Proteins
5%
Metabolite
5%
Single-Nucleotide Polymorphism
5%
Wild Type
5%
Binding Site
5%
DNA Methylation
5%
Luciferase
5%